Asia Capital (538777)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades slightly below book value: P/B of 0.98 against book value of ₹16.16
• Positive tangible book value provides per-share asset backing
• Stock is near the bottom of its 52-week range, suggesting much of the decline may already be reflected
• ROCE of 6.44% is higher than ROE, implying some operating efficiency before financing costs

Concerns

• Sales down 43.75% and profit down 44.44%; latest quarter shows ₹0 sales and ₹0 profit
• Piotroski F-Score of 3/9 indicates weak financial health and possible distress
• P/E of 40.26 with zero dividend offers no earnings-based comfort
• Insufficient disclosure: promoter holding N/A, debt/equity N/A, FairStock score insufficient

AI Analysis

At ₹15.80, Asia Capital is a micro-cap NBFC with a market cap of just ₹5 crore. The first thing that catches my eye is the price-to-book ratio of 0.98—it trades slightly below book value of ₹16.16. Graham would say an asset play is only as good as the assets behind it, and here the balance sheet data is thin. The latest quarter shows zero sales and zero profit. Trailing numbers show sales down 43.75% and profit down 44.44%, so the business is shrinking, not compounding. A P/E of 40.26 on collapsed earnings is not attractive in absolute terms; it only reflects how little remains. ROE is only 3.42%, which is far below what I would expect from a good financial company. ROCE is 6.44%, but with debt/equity not available, I cannot judge leverage properly. A Piotroski F-score of 3 out of 9 is a serious red flag; it suggests poor operating efficiency, weak profitability, and possible financial deterioration. Also, with no dividend and promoter holding not disclosed, I lack the alignment and transparency I need. The 52-week range shows the stock has fallen from ₹65.02 to around ₹15.80, a huge drop; cheap on the surface can become cheaper if the business keeps deteriorating. The FairStock score is insufficient due to lack of data—another reminder that I would be investing blind. Would I call this a wonderful business? No. It has no visible moat, no growth, and no earnings in the latest quarter. As a value investor, I demand evidence of recovery, asset quality, and management integrity. The low P/B gives a possible margin of safety, but a value trap is also a risk. I need to see stabilized earnings, positive cash flow, and full disclosure before committing capital. Until then, this is a 'watch and verify' case, not a buy.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer